Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Cantor Fitzgerald upgraded shares of Tourmaline Bio (NASDAQ:TRML – Free Report) to a strong-buy rating in a report published ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

Cantor Fitzgerald analyst Andres Sheppard initiates coverage on PureCycle Technologies, Inc. (NASDAQ:PCT) with an Overweight ...

Stifel has recently initiated Janux Therapeutics Inc (JANX) stock to Buy rating, as announced on September 6, 2024, according to Finviz. Earlier, on May 30, 2024, Scotiabank had initiated the stock to ...

CME Group Inc. is amping up the battle for market share in US Treasury futures, pulling all stops to thwart Howard Lutnick’s ...

Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham ...

Elevance Health Inc. ELV reported weaker-than-expected earnings for its third quarter on Thursday.

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

The VanEck Uranium and Nuclear ETF NLR has advanced 15.7% so far in October, on track to score it best month since April 2009. The Global X Uranium ETF URA is up around 17% in the same period, with ...

Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Arcellx Inc (ACLX – Research Report) today and set a price target of ...